© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep
Based on recent data, Immix Biopharma, Inc. (IMMX) shows an Average True Range (ATR) of 0.57 and an Enterprise Value of 38.71M. Its average trading volume over the past 3 months is 1.69M, indicating liquidity. These fundamental metrics provide insight into IMMX's underlying financial health and market activity.
| ATR | 0.57 |
| Enterprise Value | 38.71M |
| Avg Vol (3 Months) | 1.69M |
| Avg Vol (10 Days) | 2.05M |
Immix Biopharma, Inc. (IMMX) technical indicators as of July 24, 2026: the SMA 20 is 18.32%, SMA 50 at 40.13%, and SMA 200 at 133.52%. The RSI 14 value is 70.58, suggesting its current momentum. These technical analysis signals help assess IMMX's price trends and potential future movements.
| SMA 20 | 18.32% |
| SMA 50 | 40.13% |
| SMA 200 | 133.52% |
| RSI 14 | 70.58 |
Immix Biopharma, Inc. (IMMX) stock performance overview as of July 24, 2026: The 52-week high is $12.14 (currently -5.35% below), and the 52-week low is $1.94 (currently 533.58% above). Over the past year, IMMX's performance is 123.3%, compared to the S&P 500's 3.87% change.
| 52-Week High | 12.14 |
| 52-Week High Chg | -5.35% |
| 52-Week Low | 1.94 |
| 52-Week Low Chg | +533.58% |
| S&P 500 52-Week Chg | 3.87% |
According to market data, Immix Biopharma, Inc. (IMMX) stock's recent performance metrics show that over the last month, IMMX is -17.27%, with a Year-to-Date (YTD) performance of -12.05%. Over the past year, the stock has seen a 123.3% change. These figures summarize IMMX's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 10.58 | 12.14 | 12.14 | 12.14 | 12.14 | 12.14 |
| Low | 8.67 | 8.67 | 7.65 | 4.18 | 1.94 | 4.18 |
| Performance | +3.60% | -17.27% | +60.28% | +53.85% | +123.30% | -12.05% |
According to current financial data, IMMX stock's P/E (TTM) ratio is -9.74, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for IMMX, including P/S (N/A), P/B (4.07), and P/FCF (-14.87), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | IMMX | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -9.74 | -1.24 | -194.78 | 32.59 |
| P/S (TTM) | N/A | 3.68 | 468.59 | 5.98 |
| P/B (TTM) | 4.07 | -108.59 | 10.67 | 5.51 |
| P/FCF (TTM) | -14.87 | -2.81 | -627.61 | 31.16 |